This assay is to provide NALM6-based In Vivo Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NALM6
Target Cell Organism
Human
Target Cell Background
Nalm6 is a B cell precursor leukemia cell line initiated from an adolescent male. It is a CD24-positive xenograft model of acute lymphoblastic leukemia.
Target Cell Alternative Name
NALM-6
Related Diseases
Acute lymphoblastic leukemia; ALL
Research Area
Oncology
Assay Name
In Vivo Anti-Tumor Efficacy Assay
Short Description
NALM6-cell based In Vivo Anti-Tumor Efficacy Assay
Assay Description
After positive anti-tumor efficacy data is concluded using in vitro assays, we can start to initiate in vivo anti-tumor efficacy studies. Creative Biolabs offers a wide variety of PDX or CDX models to facilitate the efficacy studies. This assy will be used to evaluate the anti-tumor efficacy of your therapeutic candidates, such as small molecules, antibodies, CARTs or other biologics. Detailed group set up and other plans will be discussed according to your specific requirements.